Osiris Therapeutics, Inc. (OSIR)
24.00 Up 13.34 (+125.14%)
pero si entrais ... controlar
Form 8-K for OSIRIS THERAPEUTICS, INC.
--------------------------------------------------------------------------------
13-Aug-2013
Regulation FD Disclosure, Other Events
ITEM 7.01 Regulation FD Disclosure
On August 13, 2013, Osiris Therapeutics, Inc. issued a press release announcing the results of the planned interim analysis of the data from its multi-center, randomized, controlled clinical trial (Protocol 302) comparing the safety and efficacy of Grafix� to standard of care. The full text of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
